Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

HIV smokers get a helping hand: group therapy tested

NCT ID NCT02072772

Disease control Sponsor: Montefiore Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a special group therapy program called Positively Smoke Free helps people living with HIV quit smoking better than standard care. 450 HIV-positive smokers who wanted to quit took part. The main goal was to see if more people stayed smoke-free for 6 months with the group therapy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Positively Smoke Free group therapy (behavioral intervention)
What this could lead to
If successful, this could provide an effective, low-cost way to help people with HIV quit smoking, improving their overall health.
What could go wrong
This is a completed behavioral study, not a drug trial. Results may not apply to all HIV+ smokers, and quitting success depends on individual motivation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

450 people

The number who actually took part.

Started

May 2014

Finished

Mar 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * HIV-infection * Receives care at Montefiore Medical Center or Georgetown University * Motivated to quit * Willing to attend eight 90 minute group sessions Exclusion Criteria: * Pregnancy or breastfeeding * Contraindication to nicotine patch use

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease nicotine dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Tobacco use in persons living with HIV

Contacts and locations

Locations

  • Georgetown University Medical Center

    Washington D.C., District of Columbia, 20007, United States

  • Montefiore Medical Center

    The Bronx, New York, 10804, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.